Treatment of Livedoid Vasculopathy With Baricitinib
- PMID: 35353137
- DOI: 10.1001/jamadermatol.2022.0241
Treatment of Livedoid Vasculopathy With Baricitinib
Comment in
-
Refractory livedoid vasculopathy successfully treated with baricitinib.Int J Dermatol. 2023 Sep;62(9):1204-1205. doi: 10.1111/ijd.16467. Epub 2022 Nov 8. Int J Dermatol. 2023. PMID: 36349427 No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
